default author photo

Arvind Dasari

University of Texas at Houston - MD Anderson Cancer Center

Unit 1905

Houston, TX

United States

  • University of Texas at Houston - MD Anderson Cancer Center

SCHOLARLY PAPERS

1

DOWNLOADS

32

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Efficacy and Toxicity of Anti-Vascular Endothelial Growth Receptor Tyrosine Kinase Inhibitors in Patients with Neuroendocrine Tumors – A Systematic Review and Meta-Analysis

Number of pages: 9 Posted: 20 Sep 2022
Satya Das, Sharon Phillips, Cody Lebeck Lee, Rajiv Agarwal, Emily Bergsland, Jonathan Strosberg, Jennifer A. Chan, Heather LaFerriere, Robert A. Ramirez, Jordan Berlin and Arvind Dasari
Vanderbilt University - Division of Hematology and Oncology, Vanderbilt University - Department of Biostatistics, Vanderbilt University - Division of Hematology and Oncology, Vanderbilt University - Division of Hematology and Oncology, University of California, San Francisco (UCSF) - Department of Medicine, H. Lee Moffit Cancer Center, Harvard University - Dana-Farber Cancer Institute, Vanderbilt University, Vanderbilt University - Division of Hematology and Oncology, Vanderbilt University - Division of Hematology and Oncology and University of Texas at Houston - MD Anderson Cancer Center
Downloads 32 (1,290,922)

Abstract:

Loading...

Anti-vascular endothelial growth factor, receptor tyrosine kinase inhibitors, neuroendocrine tumors, toxicity, objective response rate, progression-free survival, systematic review & meta-analysis